MiRNA-584-3p Inhibits Gastric Cancer Progression by Repressing Yin Yang 1- Facilitated MMP-14 Expression

Overview

Journal Sci Rep

Specialty Science

Date 2017 Aug 23

PMID 28827574

Citations 37

Authors

Liduan Zheng

Yajun Chen

Lin Ye

Wanju Jiao

Huajie Song

Hong Mei

Dan Li

Feng Yang

Huanhuan Li

Kai Huang

Qiangsong Tong

Affiliations

Soon will be listed here.

Abstract

Recent evidence shows the emerging roles of promoter-targeting endogenous microRNAs (miRNAs) in regulating gene transcription. However, miRNAs affecting the transcription of matrix metalloproteinase 14 (MMP-14) in gastric cancer remain unknown. Herein, through integrative mining of public datasets, we identified the adjacent targeting sites of Yin Yang 1 (YY1) and miRNA-584-3p (miR-584-3p) within MMP-14 promoter. We demonstrated that YY1 directly targeted the MMP-14 promoter to facilitate its expression in gastric cancer cells. In contrast, miR-584-3p recognized its complementary site within MMP-14 promoter to suppress its expression. Mechanistically, miR-584-3p interacted with Argonaute 2 to recruit enhancer of zeste homolog 2 and euchromatic histone lysine methyltransferase 2, resulting in enrichment of repressive epigenetic markers and decreased binding of YY1 to MMP-14 promoter. miR-584-3p inhibited the in vitro and in vivo tumorigenesis and aggressiveness of gastric cancer cells through repressing YY1-facilitated MMP-14 expression. In clinical gastric cancer tissues, the expression of YY1 and miR-584-3p was positively or negatively correlated with MMP-14 levels. In addition, miR-584-3p and YY1 were independent prognostic factors associated with favorable and unfavorable outcome of gastric cancer patients, respectively. These data demonstrate that miR-584-3p directly targets the MMP-14 promoter to repress YY1-facilitated MMP-14 expression and inhibits the progression of gastric cancer.

Citing Articles

Non-coding RNAs participate in interactions between senescence and gastrointestinal cancers.

Liu Z, Ji F, Piao Y Front Genet. 2025; 15():1461404.

PMID: 39831201 PMC: 11739115. DOI: 10.3389/fgene.2024.1461404.

Development and preliminary validation of five miRNAs for lung adenocarcinoma prognostic model associated with immune infiltration.

Yang H, Hua J, Han Y, Chang D, Zheng W Sci Rep. 2025; 15(1):528.

PMID: 39747924 PMC: 11695782. DOI: 10.1038/s41598-024-84128-2.

In vitro and ex vivo screening of microRNA combinations with enhanced cell penetrating peptides to stimulate intervertebral disc regeneration.

Ni Neill T, Barcellona M, Wilson N, OBrien F, Dixon J, Curtin C JOR Spine. 2024; 7(4):e1366.

PMID: 39726900 PMC: 11669629. DOI: 10.1002/jsp2.1366.

Identifying X-chromosome variants associated with age-related macular degeneration.

Grunin M, Igo Jr R, Song Y, Blanton S, Pericak-Vance M, Haines J Hum Mol Genet. 2024; 33(24):2085-2093.

PMID: 39324238 PMC: 11630753. DOI: 10.1093/hmg/ddae141.

Insight into the Role of the miR-584 Family in Human Cancers.

Braile M, Luciano N, Carlomagno D, Salvatore G, Orlandella F Int J Mol Sci. 2024; 25(13).

PMID: 39000555 PMC: 11242779. DOI: 10.3390/ijms25137448.

References

Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang J . MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res. 2011; 1389:9-18. DOI: 10.1016/j.brainres.2011.03.013. View

Tang S, Mishra M, Frazier D, Moore M, Inoue K, Deora R . Positive and negative regulation of prostate stem cell antigen expression by Yin Yang 1 in prostate epithelial cell lines. PLoS One. 2012; 7(4):e35570. PMC: 3334921. DOI: 10.1371/journal.pone.0035570. View

Petrella B, Lohi J, Brinckerhoff C . Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma. Oncogene. 2004; 24(6):1043-52. PMC: 1847637. DOI: 10.1038/sj.onc.1208305. View

Sounni N, Roghi C, Chabottaux V, Janssen M, Munaut C, Maquoi E . Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. J Biol Chem. 2004; 279(14):13564-74. DOI: 10.1074/jbc.M307688200. View

Pappano W, Guo J, He Y, Ferguson D, Jagadeeswaran S, Osterling D . The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia. PLoS One. 2015; 10(7):e0131716. PMC: 4492996. DOI: 10.1371/journal.pone.0131716. View

Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba M . PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002; 18(2):333-4. DOI: 10.1093/bioinformatics/18.2.333. View

Nicholson S, Whitehouse H, Naidoo K, Byers R . Yin Yang 1 in human cancer. Crit Rev Oncog. 2012; 16(3-4):245-60. DOI: 10.1615/critrevoncog.v16.i3-4.80. View

Li D, Zhao X, Xiao Y, Mei H, Pu J, Xiang X . Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer. Oncotarget. 2015; 6(18):16168-82. PMC: 4599263. DOI: 10.18632/oncotarget.3753. View

Wang G, Hu N, Yang H, Wang L, Su H, Wang C . Comparison of global gene expression of gastric cardia and noncardia cancers from a high-risk population in china. PLoS One. 2013; 8(5):e63826. PMC: 3661768. DOI: 10.1371/journal.pone.0063826. View

10.

Griffiths-Jones S . The microRNA Registry. Nucleic Acids Res. 2003; 32(Database issue):D109-11. PMC: 308757. DOI: 10.1093/nar/gkh023. View

11.

Mei H, Lin Z, Tong Q . The roles of microRNAs in neuroblastoma. World J Pediatr. 2014; 10(1):10-6. DOI: 10.1007/s12519-014-0448-2. View

12.

Qian Z, Zhu G, Tang L, Wang M, Zhang L, Fu J . Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets. Genes Chromosomes Cancer. 2014; 53(11):883-94. DOI: 10.1002/gcc.22196. View

13.

Kang W, Tong J, Chan A, Zhao J, Dong Y, Wang S . Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma. J Transl Med. 2014; 12:80. PMC: 3986816. DOI: 10.1186/1479-5876-12-80. View

14.

Wu S, Kasim V, Kano M, Tanaka S, Ohba S, Miura Y . Transcription factor YY1 contributes to tumor growth by stabilizing hypoxia factor HIF-1α in a p53-independent manner. Cancer Res. 2013; 73(6):1787-99. DOI: 10.1158/0008-5472.CAN-12-0366. View

15.

Infante T, Mancini F, Lanza A, Soricelli A, de Nigris F, Napoli C . Polycomb YY1 is a critical interface between epigenetic code and miRNA machinery after exposure to hypoxia in malignancy. Biochim Biophys Acta. 2015; 1853(5):975-86. DOI: 10.1016/j.bbamcr.2015.01.009. View

16.

Cheng L, Wang P, Yang S, Yang Y, Zhang Q, Zhang W . Identification of genes with a correlation between copy number and expression in gastric cancer. BMC Med Genomics. 2012; 5:14. PMC: 3441862. DOI: 10.1186/1755-8794-5-14. View

17.

Piriyapongsa J, Bootchai C, Ngamphiw C, Tongsima S . microPIR: an integrated database of microRNA target sites within human promoter sequences. PLoS One. 2012; 7(3):e33888. PMC: 3306312. DOI: 10.1371/journal.pone.0033888. View

18.

Wang H, Hertlein E, Bakkar N, Sun H, Acharyya S, Wang J . NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes. Mol Cell Biol. 2007; 27(12):4374-87. PMC: 1900043. DOI: 10.1128/MCB.02020-06. View

19.

Ueno K, Hirata H, Shahryari V, Chen Y, Zaman M, Singh K . Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma. Br J Cancer. 2010; 104(2):308-15. PMC: 3031891. DOI: 10.1038/sj.bjc.6606028. View

20.

Busuttil R, George J, Tothill R, Ioculano K, Kowalczyk A, Mitchell C . A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal response. Clin Cancer Res. 2014; 20(10):2761-72. DOI: 10.1158/1078-0432.CCR-13-3049. View